Alumis (ALMS) Interest Coverage Ratio (2023 - 2025)

Alumis' (ALMS) quarterly Interest Coverage Ratio came in at 50.26 in Q4 2025, up 37.68% year-on-year from 36.5 in Q4 2024, and down 644.64% on a QoQ basis from 6.75 in Q3 2025.

Alumis (ALMS) Interest Coverage Ratio (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Interest Coverage Ratio data on file, last reported at 50.26 in Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 37.68% year-over-year to 50.26 in Q4 2025; TTM through Dec 2025 was 80.25, a 21.16% decrease from a year earlier, with the FY2025 full-year figure at 1.55, up 93.91% from the prior year.
  • Interest Coverage Ratio for Q4 2025 stood at 50.26, down from 6.75 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for ALMS reached as high as 1.98 in Q3 2024 and fell as low as 80.64 in Q4 2024.
  • Historically, Interest Coverage Ratio has averaged 29.59 across 3 years, with a median of 27.22 in 2023.
  • Across the five-year window, Interest Coverage Ratio jumped 96.35% in 2024 and plunged 240.16% in 2025, its largest moves.
  • Year by year, Interest Coverage Ratio stood at 34.51 in 2023, then sank by 133.69% to 80.64 in 2024, then surged by 37.68% to 50.26 in 2025.
  • Per Business Quant data, the three most recent Interest Coverage Ratio figures were 50.26 in Q4 2025, 6.75 in Q3 2025, and 2.47 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 658.42
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 7.60
4 NuCana 279.75 Bn 279.75 Bn - -0.22
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.71
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.72
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -0.38
10 Alumis 2.41 Bn 2.10 Bn - -50.26

Historic Data

Download Data
DateValue
Dec 31, 2025 -50.26
Sep 30, 2025 -6.75
Jun 30, 2025 -2.47
Mar 31, 2025 -19.94
Dec 31, 2024 -80.64
Sep 30, 2024 -1.98
Jun 30, 2024 -9.78
Mar 31, 2024 -35.25
Dec 31, 2023 -34.51
Sep 30, 2023 -54.36